Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

LUPIN LTD.

NSE : LUPINBSE : 500257ISIN CODE : INE326A01037Industry : Pharmaceuticals & DrugsHouse : Lupin

BSE1659.957.45 (+0.45 %)

PREV CLOSE ( ) 1652.50

OPEN PRICE ( ) 1670.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 3093

TODAY'S LOW / HIGH ( )1648.50 1679.90

52 WK LOW / HIGH ( )766.05 1703.8

NSE1660.308.55 (+0.52 %)

PREV CLOSE( ) 1651.75

OPEN PRICE ( ) 1652.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 42384

TODAY'S LOW / HIGH( ) 1648.60 1666.00

52 WK LOW / HIGH ( )769.6 1704.25

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 01-03 1983

Management Info

Manju D Gupta - Chairman Nilesh Gupta - Managing Director

Registered Office

Address Kalpataru Inspire, 3rd Floor,Off. Western Express Highway,Santacruz (East),
Mumbai,
Maharashtra-400055

Phone 022 66402323

Email info@lupin.com

Website www.lupin.com

Registrars Details

Link Intime India Pvt Ltd.

C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai

Listing : BSE, NSE, MCX

NEWS

10May Announcement under Regulation 30 (LOD
Intimation regarding grant of 5000 Stock Options under ESOP 2014.

09May Lupin informs about press release
Lupin has enclosed a Press Release as regards, appointment of Jeffrey Ki..

07May Lupin reports 52% rise in Q4 consolida
Lupin has reported results for fourth quarter (Q4) and year ended March..

07May VA Tech Wabag, Lupin and Mastek to see
VA Tech Wabag has secured a repeat order from Office National De L’assai..

07May Lupin falls despite reporting 52% rise
Lupin is currently trading at Rs. 1605.95, down by 73.80 points or 4.39%..

Financials

Rs. in Millions

	QTR Mar 24	ANNUAL 24
Net Profit	3840.8	23260.9
Gross Profit	4281.6	27846.9
Operating Profit	7316.9	35657.9
Net Sales	33958.8	146665

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Abbott India (BSE) 26643.70 (0.58%)	M.Cap ( in Cr)56616.00
Pfizer (BSE) 4473.85 (1.59%)	M.Cap ( in Cr)20466.85
Glaxosmithkline Phar (BSE) 2355.75 (2.80%)	M.Cap ( in Cr)39907.83
Concord Biotech (BSE) 1494.85 (4.43%)	M.Cap ( in Cr)15638.55
Zydus Lifesciences (BSE) 1104.45 (5.00%)	M.Cap ( in Cr)111133.51

Shareholding Pattern

	PROMOTERS	47.01%
	MUTUAL FUNDS/UTI	16.82%
	FI/BANKS/INSURANCE	10.02%
	NON-INSTITUTION	6.93%
	GOVERNMENT	0.01%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
Tata India Pharma &...	9.39
Nippon India Pharma...	8.40
DSP Healthcare Fund...	7.51
HDFC Pharma and Hea...	6.26
ITI Pharma & Health...	6.00
Nippon India Nifty ...	5.98
ICICI Pru Nifty Pha...	5.98

Risk Disclosures on Derivatives

Smart Quotes

LUPIN LTD.